Journal Of Clinical Oncology (jco) Podcast
Risky Business: PD-1 Immune Checkpoint Blockade in Thymic Epithelial Neoplasms
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:08:40
- Mas informaciones
Informações:
Sinopsis
This podcast discusses the important risks and potential benefits of PD-1 immune checkpoint blockade in patients with thymic epithelial neoplasms. Read the related article "Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial" on JCO.org
